CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for JSR Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

JSR Corp
C/O Patterson Belknap C/O Herman Raspe
1133 Avenue Of The Americas
Phone: +81 362183500p:+81 362183500 MINATO-KU, TKY  105-8640  Japan Fax: +81 362183682f:+81 362183682
Business Summary
JSR Corp mainly conducts digital solutions business, life science business and synthetic resin business. The Company operates in three business segments. The Digital Solution Business manufactures and sells semiconductor materials, display materials and edge computing related products. The Life Science segment is engaged in diagnostic and research reagents and materials, bioprocess materials and drug discovery support services. The Elastomers segment includes synthetic rubbers such as styrene and butadiene rubber, butadiene rubber, and ethylene and propylene rubber, refined processed products, thermoplastic elastomers and processed products, latexes for paper processing, latexes for general industrial use, acrylic emulsions, high-performance dispersants, as well as chemical products such as industrial particles, thermal insulation paint materials, battery materials, and butadiene monomers. The Synthetic Resin segment manufactures and sells acrylonitrile butadiene styrene (ABS) resins.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20243/31/2024Yes--YesYes

Industries
SIC Code Description
3674 Semiconductors and related devices
3679 Electronic components, not elsewhere classified
2835 In vitro and in vivo diagnostic substances
2822 Synthetic rubber (vulcanizable elastomers)
2869 Industrial organic chemicals, not elsewhere classified
2671 Packaging paper and plastics film, coated and laminated
3081 Unsupported plastics film and sheet
8731 Commercial physical and biological research
2821 Plastics materials, synthetic resins, and nonvulcanizable elastomers

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, President of Subsidiary, Representative Director EricJohnson 63 6/16/2023 6/1/2011
Chief Financial Officer, Executive Officer KenichiEmoto 50 6/27/2024 6/1/2021
Chief Human Resource Officer, Senior Executive Officer ReikoYasue 6/27/2024 6/27/2024
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Crown Bioscience International TAIPEI Taiwan
MEDICAL&BIOLOGICAL LABORATORIES CO., LTD 3-5-10 Marunouchi NAGOYA-SHI ACH Japan
Crown Bioscience, Inc. 16550 West Bernardo Drive San Diego CA United States
8 additional Subsidiary records available in full report.

Business Names
Business Name
4185
CMIC JSR Biologics Co., Ltd
Crown Bioscience International
62 additional Business Names available in full report.

General Information
Number of Employees: 7,997 (As of 3/31/2024)
Outstanding Shares: 207,635,590 (As of 3/31/2024)
Shareholders: 11,508
Stock Exchange: TYO
Fax Number: +81 362183682


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024